In the original article, there were errors.
In the abstract, “(Declaration of Taipei)” was deleted; in the 1 Introduction section, “1948, in its second year” was changed to “in its second and third years”; in the 4 Individual Participant Data (IPD) Sharing and Trial Registration Requirement section, parenthesis before and after “Supplementary Material”.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Author contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work and approved it for publication.
Conflict of interest
JB is an employee of LIF; AC is an employee of Pfizer Biopharmaceuticals Group; LC is an employee of Craveri Pharma; LF is an employee of Eli Lilly & Co.; SN is an employee of Ferozsons Laboratories Ltd.; JS is an executive consultant of PPH plus GmbH & Co. KG, Hochheim am Main.
The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Summary
Keywords
research ethics, data science, medicines development, privacy protection, data sharing, declaration of Helsinki, declaration of Taipei
Citation
Kurihara C, Baroutsou V, Becker S, Brun J, Franke-Bray B, Carlesi R, Chan A, Collia LF, Kleist P, Laranjeira LF, Matsuyama K, Naseem S, Schenk J, Silva H, Kerpel-Fronius S and on behalf of Working Group on Ethics of the International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical Medicine (2021) Corrigendum: Linking the Declarations of Helsinki and of Taipei: Critical Challenges of Future-Oriented Research Ethics. Front. Pharmacol. 11:637775. doi: 10.3389/fphar.2020.637775
Received
04 December 2020
Accepted
23 December 2020
Published
08 February 2021
Volume
11 - 2020
Edited and reviewed by
Joseph O. Fadare, Ekiti State University, Nigeria
Updates
Copyright
© 2021 Kurihara, Baroutsou, Becker, Brun, Franke-Bray, Carlesi, Chan, Collia, Kleist, Laranjeira, Matsuyama, Naseem, Schenk, Silva and Kerpel-Fronius.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Chieko Kurihara, chieko.kurihara@nifty.ne.jp
This article was submitted to Pharmaceutical Medicine and Outcomes Research, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.